It has been repotted that in the medial nucleus accumbens (NAc) there are nerve terminals which contain either the neuropeptide cholecystokinin (CCK) or the catecholamine dopamine (DA), as well as terminals which contain both. In this study, we have examined the action of CCK-peptides on the basal and potassium-evoked release of [3H]DA within this structure. The in vivo release of [3H]DA, newly synthesized from [3H]tyrosine, was measured by using the pushpull cannula perfusion technique.
It has been repotted that in the medial nucleus accumbens (NAc) there are nerve terminals which contain either the neuropeptide cholecystokinin (CCK) or the catecholamine dopamine (DA), as well as terminals which contain both. In this study, we have examined the action of CCK-peptides on the basal and potassium-evoked release of [3H]DA within this structure. The in vivo release of [3H]DA, newly synthesized from [3H]tyrosine, was measured by using the pushpull cannula perfusion technique.
It appeared that a large percentage of the [3H]DA released under resting conditions was dependent upon nerve impulse activity as it was found that tetrodotoxin, absence of extracellular Ca*+, and the inhibition of DA synthesis by a-methylp-tyrosine all decreased [3H]DA release by more than 50%. In addition, the potassium-evoked release of [3H]DA was found to be almost completely dependent upon extracellular Ca*+.
When sulfated CCK-octapeptide was administered into the NAc, it was found to increase the basal levels of [3H]DA released at concentrations of 2 x lo-' and 2 x lo-' M. However, at 2 x lo-' M there was no longer an effect by this peptide. The unsulfated form was found to have no effect at a concentration which was maximally effective for the sulfated form. In contrast to its effects on the basal release of [3H]DA, sulfated CCK-octapeptide was found to attenuate the potassium-evoked release of [3H]DA from the NAc in a concentration-dependent fashion from 2 x lo-' to 2 x 10e6 M. The unsulfated form of the octapeptide had no effect on evoked release.
Our results suggest that CCK acts to modulate the release of DA within the NAc in vivo in a complex manner, as it appears that the action of CCK depends not only on the concentration tested but also on the excitation state of the tissue during the testing period.
In recent years, a number of peptides have been found in the brain which were originally isolated from the gut. One such peptide is cholecystokinin (CCK). lmmunohistochemical and radioimmunological studies have demonstrated that CCK is found in most regions of the brain, predominantly as the sulfated carboxy terminal octa-peptide (CCK-8s) with trace amounts of other forms present , and CCK4) (Dockray, 1976; Larsson and Rehfeld, 1979; Beinfeld, et al., 1981) as well. CCK8S is a strong neurotransmitter candidate based on evidence that: (a) it is synthesized and stored by specific neurons in the brain (Emson et al. 1980; Goltermann et al., 1981) ; (b) it is released under physlological conditions (Pinget et al., 1979) and can be inactivated after release (Deschodt-Lanckman et al., 1981) ; (c) there are specific CCK receptors located in regions where the peptide is present (Hays, et al., 1980; Zarbin et al., 1983) ; and (d) it, but not CCK8US, can alter the firing rates of neurons when applied iontophoretically (Dodd and Kelly, 1981; Skirboll et al., 1981; Morin et al., 1983; White and Wang, 1984) .
Recently, Hokfelt et al. (1980) reported that CCK was co-localized with the catecholamine dopamine (DA) in a subset of neurons in the A10 region of the ventral tegmental area of the rat. In studies which combined fluorescent dye retrograde tracing techniques with immunohistochemistry, it was demonstrated that these CCK/DA neurons project primarily to the medial aspects of the nucleus accumbens (NAc) and olfactory tubercle (Hokfelt et al., 1980; Fallon et al., 1983) . These findings were further supported by studies utilizing medial forebrain bundle transections and 6-hydroxydopamine lesioning of A10 DA cells in which CCK and DA were consistently depleted only in the medial NAc (Studler et al., 1981; Marley et al., 1982; Gilles et al., 1983) . In addition, a recent report provides evidence that CCK might share the same storage sites as DA in some of the meso-accumbens terminals (Studler et al., 1984) . Since the first reports of CCK/DA coexistence appeared, there has been an increasing number of studies examining the interaction of CCK and DA in the brain. However, despite this increase in studies, the consequence of CCK-DA interaction within the brain has still not been elucidated. Behavioral studies have reported that CCK can increase, decrease, or have no effect upon DA-mediated behaviors such as stereotypy and locomotor activity (Diamond et al., 1983; Van Ree et al., 1983; Widerlov et al., 1983; Hamilton et al., 1984) . Electrophysiological studies have demonstrated that CCK8s is excitatory on some A9 and Al 0 DA cell bodies (Skirboll et al.,, 1981) as well as on medial NAc neurons (White and Wang, 1984) when applied by itself, yet it potentiates DA autoreceptor-induced inhibition of firing rate when administered immediately before the DA agonist apomorphine (Hommer and Skirboll, 1983) . Results obtained in neurochemical studies are also contrasting, as one group has reported that CCK given into the NAc has no effect on DA turnover (Widerlov et al., 1983 ), whereas Fuxe et al. (1980 reported a decrease in DA turnover in the anterior portion of the NAc. In other studies, CCK has been reported to increase (Starr, 1982) , decrease (Markstein and Hokfelt, 1984) , or have little effect (Hamilton et al., 1984) on the release of [3H]DA from striatal slices in vitro.
As there seems to be a great deal of inconsistency within the literature regarding the interaction, if any, of CCK and DA, we have Push-pull perfusion. lmmunohistochemical studies show that, in the NAc, it is the caudomedial region which contatns the highest density of CCK/DA terminals (Hokfelt et al., 1980) . Thus, we positioned our cannulae within this region in order to observe the effects of CCK on DA in an area where coexistence occurs. The procedure used is the same as that described previously (Voigt and Wang, 1984) wrth the modification that [3H]Tyr was present in the buffer (composed of (in mrllimolar concentration): NaCI, 126.5; NaHC03, 27.5; KCI, 2.4; KYPO.,, 0.5; CaClp, 0.75; MgCI,, 0.83; NapSO.,, 0.5; glucose, 5.9; with the pH adjusted to 7.4 using 95% 0,/5% COP, v/v) at a concentration of 67 &i/ml. This was accomplished by drying the needed amount of [3H]Tyr in a vial under a stream of nitrogen, to which the necessary volume of buffer was added. In addition, the superfusates were collected as 10.min fractions in test tubes on ice containing 40 ~1 of 0.5 M thioglycolic acid. At the end of the collection period, 1 ml of 95% ethanol was added to the tubes, which were then stored at ;-20°C until analysis, no later than 72 hr post-experiment. pH]DA analysis. Superfusate fractions were adjusted to pH 6.5 to 6.9 using a 0.01 M Na-K phosphate buffer (pH 7.6) and were passed over an ion exchange column (Amberlite CG50), followed by alumina absorption chromatography using a previously published procedure (Westfall et al. 1976 ). 3H-labeled catecholamines in the final eluate were quantified using liquid scintillation spectrophotometj.
Using these techniques, the levels of 3H-catecholamine recovered were 8 to 20 times the blank value (<0.15 nCi). As the NAc contains terminals from both DA-and norepinephrine (NE)-containing neurons (Veersleg et al., 1976) it was necessary to determine the composition of the newly synthesized 3H-catecholamines recovered in the perfusate.
Therefore, in some cases the final eluates from the alumina columns were evaporated to dryness using a Speedvac (Savant Instruments, Hicksville, NY) and were redissolved in 100 ~1 of 0.4 N perchloric acid. These samples were then assayed for [3H]DA and [3H]NE content using a previously described high pressure lrqurd chromatography (HPLC) procedure (Voigt and Wang, 1984) with the additional step that I-min fractions of the effluent stream were collected after having passed through the TL-5 electrode assembly.
The radioactivity In these fractions was then quantitated using scintillation spectrophotometry and were plotted as a function of time, with the retention time of the radioactive peaks compared to those of known DA and NE standards. In experiments examining the effects of drugs on basal release, the indicated drug was given for a IO-min period in the superfusion buffer. Drug application was for 60 mm in the cases of tetrodotoxin (TTX) and a-methyl-p-tyrosine (AMPT). In experiments which examined the effects of drugs on evoked release, the following protocol was used. At 120 min after the beginning of perfusion, a 10.min pulse of high potassium buffer (56 mM K+, isotonrcally replacing Na+) was applied (S,). This was followed by a 50.min period of perfusron with control buffer. At the end of this time, another IO-min pulse of high potassium buffer (S?) with or without the test drug was administered. This stimulation period was followed by a second. 50.min period of perfusion with control buffer. At the end of this period, the rat was removed from the stereotaxic device and histology was performed.
In experiments testing the dependence of K+-evoked release on Ca*', buffer without Ca" was perfused starting 10 mm after S,. For SZ, a high potassium buffer without Ca" was presented.
This was followed by another 50.min perfusion with the Ca2+-free control buffer. All Cd+-free buffers contained 1 mM EGTA. Histology.
After each experiment, the animal was removed from the stereotaxic apparatus and was perfused intracardially using phosphatebuffered formalin. The brains were then removed and kept overnight in formalin.
Histological sections (50 pm thick) were cut using a freezing microtome and mounted onto slides. Sections were then stained using cresyl violet and counterstained with neutral red. Statistical methods.
The manner in which data were calculated is based upon methods used by Nieoullon et al. (1977) . In experiments where evoked release was measured using an Sp/SI ratio, the ratio was calculated for each animal with the results pooled according to experimental treatment. Once again, differences were analyzed using a two-tailed Student's t test, with p < 0.05 being taken as statistically significant. Animals in which the tip of the cannula was outside of the medial NAc were not Included In the data analysis.
Results
Characterization of in vivo pH]DA release.
As is shown in Figure  1 , in vivo release of [3H]DA from the NAc reached steady state within 90 min from the start of the experiment, and this steady state lasted throughout the course of the experiment, which in most cases was 200 min. As depicted in Figure 2 ; the level of basal [3H]DA release appeared to be dependent upon' the location of the cannula tip within the NAc. The highest degree of basal release was observed in the caudomedial NAc, followed by the anteromedial NAc. In experiments where the cannula was not in the NAc proper, recovered levels of [3H]DA were at background levels or barely above background. Thus, the amounts of [3H]DA recovered from various regions of the NAc correlated with the distribution of mesolimbic DA terminals within the NAc (Chronister, et al., 1980) suggesting that the pushpull system was recovering [3H]DA that had been released from a discrete, localized area of the NAc.
Administration of AMPT, an inhibitor of the rate-limiting enzyme (tyrosine hydroxylase) of DA synthesis, resulted in a decrease in the release of newly synthesized [3H]DA (Table I) . Previous reports in the literature describe some mesolimbic neurons as being spontaneously active in anesthetized rats (Skirboll et al., 1981; Wang, 1981) . Therefore, we sought to determine whether the basal release of [3H]DA observed within the NAc was due to nerve impulse flow. Tetrodotoxin (TTX) is a compound which has been shown to block the propagation of action potentials along axons. When administered locally, TTX (at 1 x 10v5 M) was found to significantly decrease the basal release of [3H]DA. Neurotransmitter release is thought to be a Ca*+-mediated process; therefore, we investigated the Ca A 10.7 the perfusion buffer resulted in a decrease in basal release ( Table  I ), suggesting that a major portion of spontaneous release occurred via a calcium-dependent mechanism. This result, in combination with the effects of TTX and AMPT, suggests that roughly 50% of the basal release observed within the NAc occurred as a result of nerve impulse traffic.
Presentation of a buffer containing a high concentration of potassium (56 mM) for 10 min into the NAc resulted in a marked increase in the release of [3H]DA (Table I) . As a means of providing an internal control for each animal, an S&S, ratio protocol was used in examining the effects of compounds on the K+-evoked release of [3H]DA. In control animals, an S2/S1 ratio of 0.93 f 0.06 was obtained (see Fig.  4 ). As can be seen in Table I , omission of Ca*' almost completely blocked the stimulatory effects of 56 mM K+ during Sp, demonstrating that this form of release was occurring via physiological processes.
Effects of CCK on release. Having found that the basal release of [3H]DA was reflective of ongoing physiological processes, we proceeded to test the effects of CCK8 peptides on this release by applying them locally. The effects of both the sulfated and unsulfated forms of CCK8 were tested at various concentrations (Fig. 3) . At the two lower concentrations, CCK8S increased basal release in a dose-dependent fashion. At the higher concentration, release was not significantly different from that of control. Unsulfated CCK8 had no effect on release in a concentration at which CCK8S produced its maximal effect (2 X 10m7 M).
Experiments were also performed under conditions where [3H]DA release was increased by introducing depolarizing levels of K+ (56 mM). For these studies, CCK8 peptides were added to the perfusion buffer immediately before their infusion during the S2 period. CCK-8S caused a decrease in stimulated release at all concentrations tested. This inhibition exhibited a concentration dependency, with a greater inhibition being observed at the higher concentrations. Unsulfated CCK8 had a minor effect which did not reach statistical significance at the concentration tested (Fig. 4) .
Discussion
The results presented here extend our previous findings regarding the actions of CCK8 peptides on the in viva release of DA from the meso-accumbens terminals of the rat. Whereas in our earlier study we measured the release of DA from endogenous stores, in this study we have utilized the release of [3H]Tyr as a marker of release. This protocol was used so that the release of DA under basal [3H]DA. CCK8 peptides were added to the superfusion buffer for 10 min at the indicated concentrations, as described under "Materials and Methods."
At 20 nM, CCK8S Increased release to 155.8 f 5.8 (n = 5) compared to control, whereas 200 nM CCK8S increased release to 215.3 f 26 (n = 3) compared to control. CCK8S at 2 PM and CCK-BUS at 200 nM had no effect on basal release. **, p < 0.01, using two-tailed Student's t test. The numbers in parentheses are the number of animals tested.
conditions and the effects of CCK8 peptides on this release could be quantified, which is something that was not possible in our earlier study. Additionally, this protocol also allowed us to examine more selectively the effects of CCK8 peptides upon a particular compartment of releasable DA, that of the preferentially released pool of newly synthesized transmitter (Besson et al., 1969) . In our study, the C3H]DA which was released was demonstrated to be done so by physiologically relevant processes, since local administration of AMPT or TTX, a compound that blocks the propagation of action potentials along axons, decreased the resting release of [3H]DA, as did the lowering of extracellular Ca". In addition to resting release, the release of transmitter evoked by high K+ was also shown to be highly Ca" dependent (87%). The reduction by TTX of resting release might be due to a direct action upon dopaminergic axons, as previous studies have demonstrated that a portion of the mesencephalic DA cells which project to the NAc are spontaneously active (Skirboll et al., 1981; Wang, 1981) . Combined, these results indicate that a large percentage of the [3H]DA which is released within the NAc is not due to damage to terminals or to a nonspecific mechanism such as diffusion from intraterminal stores, Because the release we measured appeared to be of a physiological nature, we then examined the effects of CCK8 peptides upon the release of [3H]DA under both resting and stimulated conditions. Electrophysiological studies report that, in anesthetized rats, the percentage of NAc neurons which are spontaneously active is quite low (Pinnock et al., 1983; White and Wang, 1984) . Thus, under conditions where there is a low degree of intrinsic neuronal activity within the medial NAc, CCK8S was found to increase the amount of [3H]DA release from meso-accumbens terminals. This was seen at the lowest concentration tested (20 nM), with the effect increasing Vol. 5, No. 10, Oct. 1985 locomotor activity (Kelly et al., 1975; Van Ree et al., 1983) , whereas at higher doses (3 to 10 pg) this peptide is no longer effective in modulating this behavior (Widerlov et al., 1983 (Pinnock et al., 1983; White and Wang, 1984) . In contrast, it has been demonstrated that DA acts to inhibit NAc neurons (Woodruff et al., 1976; White and Wang, 1984) . 
